Feb
20
8:00pm
The Future of Obesity Treatment: Is There Opportunity Beyond GLP-1s?
By Center for Connected Medicine
Join leading experts for an insightful virtual panel discussion that explores how precision medicine has the potential to transform obesity care.
Why You Should Attend:
Obesity is a complex disease, influenced by genetic, behavioral, metabolic, and environmental factors. Traditional treatments often fall short due to a one-size-fits-all approach. Precision medicine approaches and frameworks offer tantalizing potential to transform obesity care by tailoring treatments to each patient's unique health profile, paving the way for enhanced effectiveness and fewer side effects.
This webinar will explore the advances in treatment from GLP-1 agonists to the future of personalized obesity treatment plans, while addressing critical topics such as:
- Why Obesity Is Hard to Treat: Understanding the causes and challenges in managing obesity.
- GLP-1 Medications in Care Plans: How these drugs are incorporated into personalized treatment strategies.
- Who Should Use GLP-1 Medications: Identifying the right candidates for this treatment.
- Overcoming Challenges: Addressing access issues, insurance hurdles, long-term use, and related health impacts.
- What’s Next After GLP-1s: Exploring future innovations in obesity treatment.
Meet the Experts:
Our panel of thought leaders in obesity treatment and precision medicine includes:
- Andres Acosta, MD, PhD, Associate Professor of Medicine, Co-Director of Nutrition Obesity Research Center, and Director of Precision Medicine for Obesity Program, Mayo Clinic
- David Rometo, MD, Clinical Director, UPMC Center for Obesity Medicine, and Clinical Associate Professor of Medicine, University of Pittsburgh
- Noor Khan, MD, Associate Program Director, UPMC Obesity Medicine Fellowship Program
Event Details:
- Date: February 20, 2025
- Time: 3:00–4:00 PM ET
0
days
0
hrs
0
min
10
sec
hosted by
CM
Center for Connected Medicine
share